LXRX Historical Earnings image   This LXRX historical earnings page last updated 8/4/2022
LXRX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/2/20220.04M
Q1 20225/5/20220.04M
Q4 20212/28/20220.01M
Q3 202111/3/20210.02M
Q2 20217/30/20210.00B
Q1 20215/6/20210.03M
Q4 20203/10/20210.00B
Q3 202010/29/20200.01B
Q2 20207/30/20200.01B
Q1 20204/27/20200.01B
Q4 20193/12/20200.01B
Q3 201911/7/20190.29B
Q2 20197/31/20190.01B
Q1 20195/1/20190.01B
Q4 20183/13/201917.07M
Q3 201811/1/20186.86M
Q2 20187/30/201813.75M
Q1 20185/3/201825.21M
Q4 20172/22/201833.05M
Q3 201711/8/201726.94M
Q2 20178/1/201712.05M
Q1 20175/2/201718.29M
Q4 20163/3/201723.04M
Q3 201611/1/201627.72M
Q2 20168/4/201620.09M
Q1 20165/3/201612.49M
Q4 20153/1/2016127.28M
Q3 201511/6/2015566000
Q2 20158/7/2015376000
Q1 20154/29/20151.79M
Q4 20143/4/201521.48M
Q3 201411/4/2014400000
Q2 20148/7/2014676000
Q1 20145/8/2014300000
Q4 20132/17/20141.41M
Q3 201311/6/20130.00B
Q2 20137/30/2013214000
Q1 20135/10/2013400000
Q4 20122/21/20130.00B
LXRX Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/2/2022-0.160
Q1 20225/5/2022-0.160
Q4 20212/28/2022-0.170
Q3 202111/3/2021-0.160
Q2 20217/30/2021-0.130
Q1 20215/6/2021-0.150
Q4 20203/10/2021-0.040
Q3 202010/29/2020-0.430
Q2 20207/30/2020-0.650
Q1 20204/27/2020-0.630
Q4 20193/12/2020-0.480
Q3 201911/7/2019-0.100
Q2 20197/31/2019-0.220
Q1 20195/1/2019-0.210
Q4 20183/13/2019-0.16
Q3 201811/1/2018-0.26
Q2 20187/30/2018-0.33
Q1 20185/3/2018-0.4
Q4 20172/22/2018-0.23
Q3 201711/8/2017-0.29
Q2 20178/1/2017-0.33
Q1 20175/2/2017-0.33
Q4 20163/3/2017-0.31
Q3 201611/1/2016-0.35
Q2 20168/4/2016-0.37
Q1 20165/3/2016-0.34
Q4 20153/1/20160.76
Q3 201511/6/2015-0.34
Q2 20158/7/2015-0.27
Q1 20154/29/2015-0.280
Q4 20143/4/20150
Q3 201411/4/2014-0.560
Q2 20148/7/2014-0.350
Q1 20145/8/2014-0.420
Q4 20132/17/2014-11.900
Q3 201311/6/2013-0.420
Q2 20137/30/2013-0.420
Q1 20135/10/2013-0.350
Q4 20122/21/2013-0.350
Quotes delayed 20 minutes

Email EnvelopeFree LXRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Lexicon Pharmaceuticals (LXRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

LYEL Historical Earnings
LYRA Historical Earnings
MACK Historical Earnings
MASI Historical Earnings
MBIO Historical Earnings
MBOT Historical Earnings
MBRX Historical Earnings
MCK Historical Earnings
MCRB Historical Earnings
MD Historical Earnings
What was the record high LXRX historical earnings result?
In terms of earnings or revenue, what is the best LXRX historical earnings result that Lexicon Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest LXRX historical earnings result was set in Q4 2015, when Lexicon Pharmaceuticals posted results of 0.76/share. The most successful revenue quarter within our data set was Q3 2019 when Lexicon Pharmaceuticals reported revenue of 0.29B.

What was the lowest Lexicon Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest LXRX has reported, and when?

✔️Accepted answer: Within our data set, the lowest LXRX historical earnings result was set in Q4 2013, when Lexicon Pharmaceuticals posted results of -11.900/share. The smallest revenue quarter within our data set was Q4 2021 when Lexicon Pharmaceuticals reported revenue of 0.01M.

On this page we presented the LXRX historical earnings date information for Lexicon Pharmaceuticals. Reviewing that LXRX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2015, when LXRX posted gaap of 0.76/share. Meanwhile the lowest LXRX historical earnings result was in Q4 2013, when LXRX posted gaap of -11.900/share. Moving to Lexicon Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2019 when LXRX reported 0.29B in revenue, while the smallest revenue quarter was Q4 2021 when LXRX reported 0.01M in revenue.

For self directed investors doing their due diligence on LXRX or any other given stock, their research can benefit from looking into all of the Lexicon Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Lexicon Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for LXRX. Thanks for visiting, and the next time you need to research LXRX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: HSIC Historical PE Ratio, OXSQ Dividend Growth Rate, ACN Price Target.

 

LXRX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.